• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.69% Nasdaq Up2.12%

    More On IGX.V

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    IntelGenx Technologies Corp. (IGX.V)

    -TSXV
    0.60 Down 0.07(10.45%) 3:59PM EST
    Add to Portfolio
    ProfileGet Profile for:
    IntelGenx Technologies Corp.
    6425 Abrams
    Ville Saint Laurent, QC H4S 1X9
    Canada - Map
    Phone: 514-331-7440
    Fax: 514-331-0436
    Website: http://www.intelgenx.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:12

    Business Summary 

    IntelGenx Technologies Corp., a drug delivery company, develops novel oral immediate-release and controlled-release products for the pharmaceutical market. Its product portfolio comprises INT0001/2004 for coronary heart failure and hypertension; INT0004/2006, an antidepressant; INT0007/2006 for the treatment of erectile dysfunction; INT0008/2007 for the treatment of migraine; INT0024/2010 for idiopathic pulmonary fibrosis; INT0027/2011 for opioid dependence; INT0028/2011 for cancer pain; INT0030/2011 for animal health; and INT0036/2012 for central nervous system disorders, as well as INT0037/2013 and INT0039/2013. The company develops its products based on three delivery platform technologies, which consist of the Multilayer Tablet technology that allows for the development of oral controlled-release products; the Oral Film technology, which allows for the delivery of pharmaceuticals to the oral cavity; and the Mucoadhesive Tablet technology for the controlled release of active substances to the oral mucosa. It also provides product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets. The company has a strategic alliance with LTS Lohmann Therapie-Systeme AG to manufacture pharmaceutical products using VersaFilm drug delivery technology; and a strategic manufacturing partnership with Pillar5 Pharma Inc. IntelGenx Technologies Corp. also has a co-development and commercialization agreement with RedHill Biopharma Ltd. for the co-development and commercialization of INT0008/2007. IntelGenx Technologies Corp. was founded in 2003 and is based in Ville Saint Laurent, Canada.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on IntelGenx Technologies Corp.

    Key Executives 
     PayExercised
    Dr. Horst G. Zerbe Ph.D., 67
    Founder, Chairman, Chief Exec. Officer and Pres
    261.00K0.00
    Mr. Paul A. Simmons AFCA, 52
    Chief Financial Officer and Principal Accounting Officer
    230.00K0.00
    Mrs. Ingrid Zerbe Montreal , 60
    Founder, Director of Fin. & Admin., Treasurer, Sec. and Controller
    N/AN/A
    Ms. Nadine Paiement MSc,
    Director of R&D
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.